Characteristics of Dihydroxyphenylalanine/5‐Hydroxytryptophan Decarboxylase Activity in Brain and Liver of Cat

@article{Bouchard1981CharacteristicsOD,
  title={Characteristics of Dihydroxyphenylalanine/5‐Hydroxytryptophan Decarboxylase Activity in Brain and Liver of Cat},
  author={Sylvie Bouchard and C{\'e}line Bousquet and Andr{\'e}e G. Roberge},
  journal={Journal of Neurochemistry},
  year={1981},
  volume={37}
}
Abstract: Dihydroxyphenylalanine/5‐hydroxytryptophan (DOPA/5‐HTP) decarboxylase activity varied widely in different parts of the CNS, being highest in the neostriatum and lowest in the frontal cortex. The addition of 2.5 μm‐pyridoxal 5′‐phosphate (PLP), the coenzyme, increased enzyme activity in brainstem and liver, while higher concentrations led to a decrease in activity. In brainstem, the addition of 1000 μm PLP shows activity similar to that obtained without exogenous PLP. The effects of… Expand
Neuronal DOPA Decarboxylase a
TLDR
The question whether AADC is a single-protein species or a group of very closely related proteins (e.g. isozymes) will be addressed in the following section. Expand
Aromatic L‐amino acid decarboxylase‐immunohistochemistry in the cat lower brainstem and midbrain
TLDR
A morphological basis for neurons that decarboxylate endogenous and exogenous L‐DOPA, 5HTP, and other aromatic L‐amino acids is provided and new additional D‐type cell groups that have not been reported in the rat are described. Expand
Aromatic l-amino acid decarboxylase-immunoreactive structures in human midbrain, pons, and medulla
TLDR
Intermediate to strong immunoreaction was observable in presumptive DA cells in the mesencephalic reticular formation, substantia nigra, and ventral tegmental area of Tsai, as well as in presumptive noradrenergic (NA) cells, which were aggregated in the locus coeruleus and dispersed in the subcoeruleus nuclei. Expand
Effect of monofluoromethyldopa (MFMD) on trace amine levels.
  • L. Dyck
  • Chemistry, Medicine
  • Life sciences
  • 1987
TLDR
While MFMD decreased the levels of all four amines in the kidney, only phenylethylamine and tryptamine levels were decreased in the striatum compared to control, and similar changes in striatal and kidney trace amine levels were observed compared to MFMD alone. Expand
Aromatic L-amino acid decarboxylase modulation and Parkinson's disease.
TLDR
Studies are presented demonstrating how AAAD activity can be enhanced in an animal model of Parkinson's disease and how rapid fluctuations of AAAD can be provoked via second messenger system activation. Expand
Cloning and characterization of DOPA decarboxylase in Litopenaeus vannamei and its roles in catecholamine biosynthesis, immunocompetence, and antibacterial defense by dsRNA-mediated gene silencing.
TLDR
The cloned LvDDC was responsible for controlling dopamine synthesis, which then regulated physiological and immune responses in L. vannamei, and was phylogenetically closely related to insect DDC. Expand
Tryptophan Uptake and Hydroxylation in Rat Forebrain Synaptosomes
TLDR
Simultaneous measurements of the rates of uptake, hydroxylation, and decarboxylation in the presence and absence of various inhibitors showed that tryptophan Hydroxylase is rate‐limiting for serotonin synthesis in this model system. Expand
Absence of decar☐ylation of some aromatic-l-amino acids by cultured astrocytes
TLDR
It is suggested that astroglial cell cultures lack aromatic-L-amino acid decarboxylase and give further evidence that these cells contain monoamine oxidase. Expand
Comparative and quantitative study of L-dopa decarboxylase mRNA in rat neuronal and non-neuronal tissues.
TLDR
The results indicate that the level of mRNA is a primary factor determining the L-DOPA decarboxylase level. Expand
Effects of benzene and other organic solvents on the decarboxylation of some brain aromatic-L-amino acids.
TLDR
Increases in brain beta-phenylethylamine, p-tyramine and m-tyramsine may play a contributory role in the human toxicity of benzene and some of these organic solvents; these toxic effects could be exacerbated after ingestion of foodstuffs containing the aminoacids phenylalanine or p-Tyrosine or for those under treatment with a monoamine oxidase inhibitor. Expand
...
1
2
3
...